"10.1371_journal.pone.0149821","plos one","2016-02-25T00:00:00Z","Anne-Li Lind; Di Wu; Eva Freyhult; Constantin Bodolea; Titti Ekegren; Anders Larsson; Mats G Gustafsson; Lenka Katila; Jonas Bergquist; Torsten Gordh; Ulf Landegren; Masood Kamali-Moghaddam","Department of Surgical Sciences, Anaesthesiology and Intensive Care and Uppsala Berzelii Technology Center for Neurodiagnostics, Uppsala University, Uppsala, Sweden; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden; Department of Medical Sciences, Cancer Pharmacology and Computational Medicine, Science for Life Laboratory, Bioinformatics Infrastructure for Life Sciences, Uppsala University, Uppsala, Sweden; Department of Anaesthesia and Intensive Care, University of Medicine and Pharmacy, Cluj, Napoca, Romania; Department of Engineering Sciences, Uppsala University, Uppsala, Sweden; Department of Medical Sciences, Biochemical Structure and Function, Uppsala University, Uppsala, Sweden; Department of Medical Sciences, Cancer Pharmacology and Computational Medicine, Uppsala University, Uppsala, Sweden; Department of Chemistry-BMC, Analytical Chemistry and Science for Life Laboratory, Uppsala University, Uppsala, Sweden","Conceived and designed the experiments: MKM TG UL ALL DW JB TE. Performed the experiments: ALL DW. Analyzed the data: EF MGG. Contributed reagents/materials/analysis tools: AL CB TG TE LK. Wrote the paper: ALL DW EF MKM UL.","U. Landegren is a co-founder and stockholder of the Olink Bioscience that commercializes the PLA technology. The other authors have declared that no competing interests exist.","2016","02","Anne-Li Lind","ALL",12,FALSE,7,2,2,5,TRUE,FALSE,FALSE,0,NA,FALSE
